Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

August 2, 2020

Influence of growth hormone therapy on the occurrence of second neoplasms in survivors of childhood cancer

European Journal of Endocrinology
Cecile Thomas-TeinturierFlorent de Vathaire
July 17, 2020
Open Access

Papillary Endothelial Hyperplasia (Masson Tumor) of the Hand. Surgical and Pathological Consideration from Seven Cases Using New Vascular Markers

Pathology Oncology Research : POR
Bernadett Bettina PataiJudit Reka Hetthessy
July 30, 2020
Open Access

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia

Oncology Letters
Guilan LiZujun Jiang
June 22, 2020
Open Access

Interstitial lung diseases in children

La Presse médicale
Nadia NathanAnnick Clement
July 30, 2020

Pediatric cancer mortality and survival in the United States, 2001-2016

David A SiegelNatasha Buchanan Lunsford
June 25, 2020
Open Access

KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma

Genes & Cancer
Lays Martin SobralPaul Jedlicka
June 20, 2020

Molecular-Targeted Therapy for Childhood Brain Tumors: A Moving Target

Journal of Child Neurology
Roger J Packer, Lindsay Kilburn
June 25, 2020
Open Access

Molecular karyotyping and gene expression analysis in childhood cancer patients

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Galetzka DanutaSchmidberger Heinz
July 24, 2020
Open Access

Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma

Oncology and Therapy
André Serra-Roma, Olga Shakhova
July 28, 2020
Open Access

Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma

International Journal of Molecular Sciences
Jessica L BellStefan Hüttelmaier
June 24, 2020
Case Report

Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?

American Journal of Medical Genetics. Part a
Marina MacchiaioloAndrea Bartuli
July 7, 2020

Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia

[Rinshō ketsueki] The Japanese journal of clinical hematology
Junko Takita
July 10, 2020
Open Access

Effects of pharmacological calcimimetics on colorectal cancer cells over-expressing the human calcium-sensing receptor

BioRxiv : the Preprint Server for Biology
July 28, 2020
Open Access

OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancer

Blood Advances
Biswajit SahaAbhishek Jain

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved